UPDATED: NPA calls decision a "win for the industry and consumers" ‘A drug-level randomized controlled clinical trial for a supplement has never been the standard’: Bayer ‘gratified’ with court decision vs FTC 29-Sep-2015 By Stephen Daniells The hotly anticipated decision in the dispute between Bayer and the US Federal Trade Commission over claims in support of Phillips’ Colon Health is in, with a judge ruling in favor of the company.
